The chairman of Zydus Lifesciences, Pankaj R Patel, stated on Friday that the Indian pharmaceutical industry can produce 100 new drugs for global markets by 2047, supported by improved research and development initiatives...
Pharmaceutical industry Cipla has obtained final approval from the United States Food and Drug Administration (USFDA) for the New Drug Application (‘NDA’) it submitted for ‘Nilotinib Capsules 50, 150, and 200 mg’...
On February 19, pharmaceutical stocks faced pressure after remarks from US President Donald Trump, indicating that the US could implement tariffs close to 25% on imports of pharmaceuticals, automobiles, and semiconductors...
On Thursday, Sun Pharmaceutical Industries announced that it has requested shareholders' consent for related-party transactions (RPTs) totaling about $1 billion for FY26...
A groundbreaking UK-India initiative, the ‘Living Laboratory’ was officially launched in Pune, India, marking a significant step toward decarbonizing the pharma industry. The state-of-the-art facility that will serve as a
Innocan Pharma Corporation, a leader in the pharmaceutical and biotechnology sectors, is pleased to declare that it has received a patent in India for a prolonged-release pharmaceutical formulation that uses liposomes to encapsulate cannabinoids...
The maximum retail price (MRP) of medications and formulations that are no longer subject to customs duty has been adjusted by the National Pharmaceutical Pricing Authority (NPPA) in accordance with this year's budget.
Aurobindo Pharma has announced that the European Commission (EC) has granted marketing authorization in the European Union (EU) for Zefylti, a filgrastim biosimilar, to CuraTeQ Biologics s.r.o., a wholly owned step-down subsidiary of the Company....
In the context of ongoing US-India discussions on tariffs, key pharmaceutical industry bodies in India—Pharmaceuticals Exports Promotion Council (Pharmexcil), Indian Pharmaceutical Association (IPA), and Indian Drug Manufacturers Association (IDMA...
Indian companies in the pharmaceutical and steel sectors remain largely unaffected by the Trump administration’s impending trade tariffs, with industry leaders downplaying concerns about their impact on Indian exports to the US.
, CDSCO.jpg)
